I have created and collaborated on numerous projects on an array of subjects. I have expertise in areas of mental health interactions with the law, psychological diagnoses, mental health treatment and others.
In addition to the formal presentations below, I have given many informal presentations to employees, coworkers, church organizations and others.
Midwestern Psychological Association’s annual conference: Psychopathy: Research and Practice Implications (April 24, 2021; Collaborator: Michelle Rabinovich).
Creve Coeur Counseling Associates: A Forensic Psychologist’s Perspective on Clinical Recordkeeping (January 9, 2021).
National Parks Service FriYay podcast series: Shifting Your Mindset in a Post Pandemic World (August 10, 2020).
Creve Coeur Counseling Associates: A Guide to Working with Incarcerated Individuals and their Families (May 2020).
Christian Counseling Connection: Suicide Risk Assessment & Treatment Approaches, (Lake Saint Louis, MO (June 2019).
Missouri Mental Health Counselors Association (MMHCA): Rethinking Our Philosophy on Mental Illness, (Lake of the Ozarks, MO (September 24-27, 2014).
Washington University of Saint Louis, Washington University Political Review. Invited panelist to discuss the American healthcare system (March 7, 2012)
National Commission on Correctional Health Care: Updates in Correctional Healthcare. Nashville, TN (April 24-27, 2010). Response to a new drug epidemic behind bars: Quetiapine. (Collaborators: Alan Felthous, M.D., Philip Wenger, Pharm.D.)
University of Missouri-Kansas City’s Department of Psychiatry Grand Rounds (April, 2006). Correlation vs. Causation: Understanding the cause and effect of mental illness.
Marks, V., Hoevet, R., Barney, K., & Eichler, J.: Project Identity: Re-entry Program Proposal. Poster presented at the Missouri Occupational Therapy Association Conference (November 14, 2014)
Eichler, Hoevet, & Royeen (2015): OTonCampus®: A focus on doing in context; Operationalizing Psychotherapy. MHSIS Quarterly.
Felthous, Wenger, and Hoevet (2010): Acute Psychosis Associated with Dissociated Sleep-Wakefulness State After Mirtazapine Treatment. Pharmacotherapy, 30 (4), p. 423.